The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis

被引:3
|
作者
Kubiliute, Aleksandra [1 ]
Gedvilaite, Greta [2 ]
Vilkeviciute, Alvita [2 ]
Kriauciuniene, Loresa [2 ]
Bruzaite, Akvile [2 ]
Zaliuniene, Dalia [3 ]
Liutkeviciene, Rasa [2 ,3 ]
机构
[1] Lithuanian Univ Hlth Sci, Med Acad, Med Fac, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Neurosci Inst, Med Acad, Lab Ophthalmol, Eiveniu Str 2, LT-50161 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Med Acad, Dept Ophthalmol, Eiveniu 2 Str, LT-50161 Kaunas, Lithuania
关键词
Optic neuritis; Multiple sclerosis; SIRT1; SNP; ELISA; NEUROPROTECTION; RESVERATROL; ACTIVATION; PROTECTS; DAMAGE; CELLS; MODEL;
D O I
10.1186/s13023-023-02665-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aimTo investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS).Methods79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0".ResultsWe discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development.ConclusionsSIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
    Aleksandra Kubiliute
    Greta Gedvilaite
    Alvita Vilkeviciute
    Loresa Kriauciuniene
    Akvile Bruzaite
    Dalia Zaliuniene
    Rasa Liutkeviciene
    Orphanet Journal of Rare Diseases, 18
  • [2] Role of SIRT1 Gene Polymorphisms and Serum Levels in Patients with Multiple Sclerosis
    Kaikaryte, Kriste
    Gedvilaite, Greta
    Balnyte, Renata
    Uloziene, Ingrida
    Liutkeviciene, Rasa
    DIAGNOSTICS, 2023, 13 (20)
  • [3] SIRT1 is decreased during relapses in patients with multiple sclerosis
    Tegla, Cosmin A.
    Azimzadeh, Philippe
    Andrian-Albescu, Maria
    Martin, Alvaro
    Cudrici, Cornelia D.
    Trippe, Richard, III
    Sugarman, Adam
    Chen, Hegang
    Boodhoo, Dallas
    Vlaicu, Sonia I.
    Royal, Walter, III
    Bever, Christopher
    Rus, Violeta
    Rus, Horea
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 96 (02) : 139 - 148
  • [4] Variant Analysis of the Sirtuin (SIRT1) Gene in Multiple Sclerosis
    Edgunlu, Tuba Gokdogan
    Celik, Sevim Karakas
    Emre, Ufuk
    Unal, Aysun Eroglu
    Dursun, Ahmet
    KUWAIT MEDICAL JOURNAL, 2013, 45 (04): : 313 - 318
  • [5] Role and therapeutic considerations of SIRT1 in epilepsy
    Zeng, Shasha
    Huang, Xiangyi
    Qu, Shunlin
    Hu, Qingpeng
    NEUROSCIENCE, 2025, 568 : 109 - 115
  • [6] The Role of Sirt1 in Epileptogenesis
    Hall, Alicia M.
    Brennan, Gary P.
    Nguyen, Tiffany M.
    Singh-Taylor, Akanksha
    Mun, Hyun-Seung
    Sargious, Mary J.
    Baram, Tallie Z.
    ENEURO, 2017, 4 (01)
  • [7] Role of SIRT1 in Chemoresistant Leukemia
    Fajardo-Orduna, Guadalupe Rosario
    Ledesma-Martinez, Edgar
    Aguiniga-Sanchez, Itzen
    Weiss-Steider, Benny
    Santiago-Osorio, Edelmiro
    Wiemer, Erik A. C.
    Camacho-Arroyo, Ignacio
    Melendez-Zajgla, Jorge
    Valverde Ramirez, Mahara A.
    Rodriguez-Dorantes, Mauricio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [8] The Role of SIRT1 in Leukemia
    Wu, Zhongqi
    Lyu, Tianxin
    Wu, Leizhen
    Yang, Hui
    Li, Wenqiang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (10) : 1283 - 1288
  • [9] Metabolic benefits from Sirt1 and Sirt1 activators
    Chaudhary, Nilika
    Pfluger, Paul T.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2009, 12 (04) : 431 - 437
  • [10] Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
    Jiang, Mali
    Wang, Jiawei
    Fu, Jinrong
    Du, Lin
    Jeong, Hyunkyung
    West, Tim
    Xiang, Lan
    Peng, Qi
    Hou, Zhipeng
    Cai, Huan
    Seredenina, Tamara
    Arbez, Nicolas
    Zhu, Shanshan
    Sommers, Katherine
    Qian, Jennifer
    Zhang, Jiangyang
    Mori, Susumu
    Yang, X. William
    Tamashiro, Kellie L. K.
    Aja, Susan
    Moran, Timothy H.
    Luthi-Carter, Ruth
    Martin, Bronwen
    Maudsley, Stuart
    Mattson, Mark P.
    Cichewicz, Robert H.
    Ross, Christopher A.
    Holtzman, David M.
    Krainc, Dimitri
    Duan, Wenzhen
    NATURE MEDICINE, 2012, 18 (01) : 153 - 158